Cargando…
Multiple drugs: COVID-19-associated invasive pulmonary aspergillosis, Off-label use and lack of efficacy: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119617/ http://dx.doi.org/10.1007/s40278-021-95910-4 |
Ejemplares similares
-
Multiple drugs: Invasive pulmonary aspergillosis, lack of efficacy and off-label therapy: 4 case reports
Publicado: (2020) -
Norepinephrine/oseltamivir: Lack of efficacy and invasive pulmonary aspergillosis secondary to off-label use: case report
Publicado: (2020) -
Multiple drugs: Invasive pulmonary aspergillosis and Off label use: 4 case reports
Publicado: (2021) -
Dexamethasone/voriconazole: Invasive aspergillosis following off-label use; lack of efficacy: case report
Publicado: (2022) -
Multiple drugs: Off label use, pulmonary aspergillosis and COVID-19 pneumonitis: case report
Publicado: (2021)